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ABSTRACT 
Modern medical conditions, including cancer, traumatic brain injury, and 
cardiovascular disease, have elicited the need for cell therapies. The ability to non-
invasively track cells in vivo in order to evaluate these therapies and explore cell dynamics 
is necessary. Magnetic Resonance Imaging provides a platform to track cells as a non-
invasive modality with superior resolution and soft tissue contrast. A new methodology for 
cellular labeling and imaging uses Nile Red doped hexamethyldisiloxane (HMDSO) 
nanoemulsions as dual modality (Magnetic Resonance Imaging/Fluorescence), dual-
functional (oximetry/detection) nanoprobes. While Gadolinium chelates and super 
paramagnetic iron oxide-based particles have historically provided contrast enhancement 
in MRI, newer agents offer additional advantages. A technique using 1H MRI in 
conjunction with an oxygen reporter molecule is one tool capable of providing these 
benefits, and can be used in neural progenitor cell and cancer cell studies. Proton Imaging 
of Siloxanes to Map Tissue Oxygenation Levels (PISTOL) provides the ability to track the 
polydimethylsiloxane (PDMS) labeled cells utilizing the duality of the nanoemulsions. 1H 
MRI based labeling of neural stem cells and cancer cells was successfully demonstrated. 
Additionally, fluorescence labeling of the nanoprobes provided validation of the MRI data 
and could prove useful for quick in vivo verification and ex vivo validation for future 
studies. 
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CHAPTER 1 
INTRODUCTION 
1.1 Cellular Labeling and Nanoprobes 
 The complexity of modern disease, from degenerative and trauma-induced 
conditions to cancer, has elicited the need for cell therapies. One such cell treatment comes 
in the form of immunotherapy to target invading cancer cells. Antigens specific to cancer 
cells can be recognized as foreign by autologous immune cells, and manipulation of the 
host immune cells to sense the foreign antigens (amongst many “non-foreign” looking 
aspects of the cancer cells) has provided a specific, cell-based treatment [1]. In comparison 
to traditional chemotherapy and radiation therapy, this advantageous method can 
distinguish cancer cells from other rapidly growing cells for a more precise treatment. 
Similarly, stem cell therapies display the potential to treat disease via integration post-
transplantation. For example, it has been shown that transplanting low doses of mouse 
embryonic stem cells into the rat striatum results in proliferation into fully differentiated 
fetal dopamine neurons in Parkinson’s patients [2]. Parkinson’s disease can be 
characterized by a decrease in dopaminergic neurons in the substantia nigra, and thus the 
stem cell therapy is beneficial. [3] 
 While these treatments are innovative and promising, definitive proof of safety and 
efficacy is needed for establishment as a clinical standard. Cell labeling and non-invasive 
tracking brings forth the ability to monitor cell dynamics in vivo, and evaluate the impact 
of cell therapies. Additionally, the ability to track cells in vivo offers many promising 
benefits throughout biomedical research. 
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 Magnetic Resonance Imaging provides a powerful tool for the aforementioned 
applications due to superior soft tissue contrast and resolution. MRI utilizes the magnetic 
properties of nuclei for the visualization of biologic samples. The modality exploits the 
high sensitivity of the 1H atom within the body from water, and to a lesser extent, lipid 
sources to non-invasively image endogenous structures and processes [4]. Exogenous 
contrast agents use the same magnetic properties to generate contrast in order to investigate 
multiple in vivo questions non-invasively (ie. cardiovascular performance, tumor detection 
in the brain, liver visualization) [5]. Recently, interest in these MRI contrast agents for 
molecular and cellular imaging applications has increased.  
 Traditionally, paramagnetic Gadolinium chelates and superparamagnetic iron oxide 
derived agents have been used for contrast enhancement. While these agents have 
historically provided contrast enhancement in MRI, newer agents offer additional 
advantages. One such technique utilizes perfluorocarbons (PFCs) as an oxygen reporter 
molecule in conjunction with 19F MRI for monitoring of fluorinated compounds. 
Perfluorocarbons contain similar structure to organic compounds with a fluorine atom 
replacing hydrogen atoms in most cases [6]. An analogous technique using 1H MRI was 
reported and is presented here. Proton Imaging of Siloxanes to Map Tissue Oxygenation 
Levels (PISTOL) provides the ability to track polydimethylsiloxane (PDMS) based 
nanoemulsions as MR contrast agents [7]. 
 Gadolinium-based nanoparticles have been used for tumor cell labeling studies and 
display increased contrast on T1-weighted images [8]. Similarly, superparamagnetic iron 
oxide (SPIO) particles have been shown to successfully label immune cells and allow for 
tracking in vivo via contrast enhancement on T2-weighted images [9]. The particles created 
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from these two contrast agents are viable options for cell labeling and tracking; however, 
other options may provide additional function benefits. Newer methods also generate 
positive contrast without background signal – this contrast arises from no signal to positive 
signal whereas Gadolinium and iron oxide alter pre-existing signal. 
 19F MRI focuses specifically on the resonance of fluorine allowing for images 
without the background of normal 1H tissue. Anatomical information from 1H MRI 
provides signal localization when overlaid with 19F MRI.  PFCs serve as oxygenation 
markers (reporting partial pressure of oxygen), and when combined with a fluorescent 
component, PFCs can be utilized as multi-functional nanoprobes [10].  
 HMDSO has also been shown as an oxygen reporter molecule (pO2), and can be 
combined with a fluorescent component to create dual-modaility (MRI/Fluorescence), 
dual-functionality (oximetry/detection) nanoprobes for cellular and molecular imaging 
[11]. These methodologies utilize 1H MRI and provide similar benefits to the PFCs used in 
conjunction with 19F MRI. The siloxane selective sequences provide images without 
traditional 1H MRI background signal through water and fat suppression (more detail in 
Chapter 1.4).  1H MRI is more advantageous clinically than 19F MRI due to the ability to 
acquire all images by exciting the 1H proton at its resonance frequncy. 19F MRI requires 
acquisition of signal from both 1H excitation and 19F excitation. This technology is 
currently not a part of established clinical scanners. 
 The aim of the project is to fabricate nanoemulsions capable of labeling and 
tracking cells using dual modality imaging – useful for quick in vivo verification and ex 
vivo validation – and focus on the different aspects of cell labeling applications. A novel 
mechanism utilizing siloxane-based nanoprobes to track cells could prove essential for the 
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treatment of a wide array of diseases. The added possibility of oximetry data using PISTOL 
is especially exciting for neural disease and cancer implications.  
 
 
Figure 1.1 Outline for the Production of Dual-Modality, Dual-functionality Nanoprobes. 
Nanoprobe synthesis is followed by direct labeling of cells. Tracking can be achieved via in vivo 
MRI studies and validated with ex vivo fluorescence data.  
   
1.2 Traumatic Brain Injury and Neural Stem Cells 
 A traumatic brain injury results from a bump, blow or jolt to the head or a 
penetrating head injury that interrupts normal function of the brain [12]. As the most 
common cause of death and disability in young people, TBI is graded as mild, moderate, 
or severe and can result in cognitive disorders and severe functional limitations [13]. The 
functional outcome of a TBI is influenced by neurological, physiological, and physical 
factors, and is heavily dependent on rehabilitation and early/late interventions for improved 
prognosis [14]. One such intervention with potential to improve functional outcome post-
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TBI is cell-based therapies involving the transplantation of neural stem cells to the affected 
brain. This project will consider tracking transplanted neural stem cells following injury.    
 Transplantation of grafted neural stem cells presents a novel option to create a 
“biobridge” between uninjured tissue and the damage site in which grafted cells send 
migratory clues to endogenous neurogenic cells for enhanced repair mechanisms [15]. 
These results can be seen extensively in Tajiri et. al through immunohistochemistry, 
zymography, behavioral and neurological testing, and cell migration data.  
 Primary and secondary neuronal loss associated with traumatic brain injury can 
cause cognitive dysfunction. Significant cognitive improvement has been shown by the 
transplantation of neural stem cells in rats following traumatic brain injury [16]. Memory 
improvements and spatial learning increased as shown by the Morris Water Maze (MWM) 
tests [16]. Similarly, transplanted neural stem cells have been shown to survive, 
differentiate and improve motor function after traumatic brain injury [17]. Cell therapies 
to improve traumatic brain injury prognosis are promising, and the ability to track the cells 
to better understand the functional mechanisms underlying these improvements are 
necessary. Successful research on stem cell therapy presents an interesting opportunity for 
further analysis utilizing non-invasive, in vivo tracking methods allowing for data 
collection over multiple time points. 
 Magnetic Resonance Imaging has proven a powerful tool for neural stem cell 
tracking following transplantation. Gadolinium is not commonly used for labeling studies 
due to toxicity concerns and potential MR susceptibility issues when internalized by a 
cell[18].  Tracking path, migration and distribution is a valuable tool to optimize potential 
treatments and has been shown using superparamagnetic iron oxide particles to label neural 
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stem cells [19, 20]. 19F MRI has also been used in conjuction with various perfluorocarbons 
to track neural stem cells in vivo [21, 22]. However, an existing clinical standard for cell 
tracking is absent, and further work should address this deficiency [19].  
 Here, the focus is on demonstrating and presenting successful neural stem cell 
labeling using fluorescence and MR imaging modalities. Additionally, ensuring 
maintained viability and functionality of the neural progenitor stem cells (NPSCs) post-
labeling is of primary concern. Utilizing dual-modality, dual-functionality nanoprobes with 
1H MRI, an additional tool for NPSC tracking and improved treatment is presented.    
 
1.3 Cancer Cell Applications 
 Magnetic Resonance-based labeling of cells has traditionally been used in various 
applications including cardiovascular disease, joint disease, aforementioned studies 
regarding the fate of stem cells in neurological disorders, and organ visualization [23]. And 
even though immune cells have been labeled for the treatment of cancer, only recently has 
interest arisen regarding paramagnetic labeling of cancer cells.  
 The process of cancer metastasis and tumor invasion has prompted the study of 
cancer cell migration patterns over long periods of time. Metastasis is a property of 
malignant cancer cells in which additional malignant cells are released from the primary 
tumor and disseminate to distant sites where they proliferate to form new tumors [24]. 
These metastases do not result from random cell survival, but rather by specialized 
subgroups of highly metastatic cells with specific properties beneficial to survival [24]. For 
this reason, along with the decreasing prognosis associated with metastatic tumors, it is 
beneficial to study the migration patterns of these malignant cells.     
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 Again superparamagnetic iron oxide nanoparticles have been show effective for 
labeling and long-term cancer cell migration studies [25]. However, many important 
considerations must be taken into account when evaluating these studies over a significant 
period of time including viability, proliferation, cell division, stability and changes in 
relaxometry. The labeling agent must remain inert to allow the cell to exhibit its specific 
properties while still maintaining the quality of producing MR contrast. Labeling with 
SPIOs has also proven useful in studying mechanisms of metastasis and tumor dormancy 
through the evolution of a single cell subset, to tumor formation [26].  
 Extensive research has shown the efficacy of SPIOs in cell labeling. Specific to 
cancer cells, a similar labeling technique using siloxane-based nanoprobes could provide 
the additional benefit of functional oximetry.  
 Tumor hypoxia relates to vasculature and physiological conditions within the tumor 
and occurs when tumor cells are deprived of oxygen. Rapidly growing cancer cells outgrow 
their blood supply, and specific malignant cells have an unusual tolerance to limited 
oxygen availability [27]. These cells are found to alter their metabolism displaying 
excessive lactate production via aerobic glycolysis, and this increased lactate production is 
a characteristic associated with malignant cells [27, 28]. An association has also been 
established between tumor hypoxia and metastasis correlating to the “angiogenic switch” 
and an increasingly poor prognosis [28, 29].  
 In order to effectively apply treatment to tumor microenvironments, it would be 
advantageous to know which region of the tumor exhibits hypoxia. Additionally, the ability 
to measure hypoxia over time and at different treatment intervals provides a unique 
opportunity in evaluating cancer therapies as opposed to histological methods. PISTOL, in 
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unison with the siloxane-based nanoprobes, presents the additional functional benefit of 
oximetry. Thus, quantifying the pO2 in the tumor microenvironment is an important aspect 
to tumor cell labeling.   
 Cancer spheroids bring forth an additional area of research susceptible to benefits 
from paramagnetic cell labeling. Tumor spheroids are multicellular structures grown in 3-
dimensional culture to emulate the growth conditions and microenvironment of real tumors 
[30]. A renewed interest in tumor spheroids has emerged recently due to the flexibility as 
a therapeutically relevant model of in vivo tumors [31]. In this way, ineffective drug 
candidates can be eliminated before advancing into animal and human testing, and 
promising drugs – proving poor in 2D culture – can be identified and accelerated into 
testing [31]. Here, oximetry data would prove a valuable asset in helping identify drug 
performance and emphasizes the importance for cancer cell labeling in conjunction with 
dual-modality imaging.  
 
1.4 Imaging Approach 
1.4.1 MRI Principles 
    At the foundation of MRI signal generation is a fundamental property of atomic 
nuclei called spin. While the actual phenomenon is quantum mechanical in nature, each 
nuclei has an intrinsic angular momentum giving rise to a magnetic moment. Spin can exist 
in an “up” or “down” state and behaves like a tiny magnet in the presence of an external 
magnetic field. However, without the presence of an external magnetic field, these spin 
states are indistinguishable.  
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 In terms of generating NMR signal, only nuclei with a net overall spin are of 
concern (ie. 1H and 19F as mentioned with regards to labeling). In the presence of an 
external magnetic field, known as B0, the nuclei will align in their distinguishable “up” and 
“down” states. At room temperature, the number of spins aligning in the “up” (higher 
energy) orientation slightly outnumber the number of spins aligning in the “down” (lower 
energy) orientation. This relationship is governed by Boltzman statistics as shown below 
                N-/N+ = e-E/kT                                                         [1] 
Where N- is the number of spins in the lower energy state, N+ is the number of spins in the 
higher energy state, E is the energy difference between spin states, k is the Boltzmann 
constant (1.3805x10-23 J/Kelvin), and T is the temperature in Kelvin. 
At this point, it is necessary to introduce the classical vector model which assumes 
a net magnetization in a bulk, macroscopic view. The higher energy spins align along the 
direction of the external magnetic field and outnumber the lower energy spins creating a 
net magnetization known as M0. 
 
Figure 1.2 Higher Energy Spins Align in the Direction of the Applied Magnetic Field.  
A net magnetic field (M0) is generated along the Z-axis in same direction as external 
magnetic field (B0). 
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In order to generate NMR signal, voltage must be produced by a varying magnetic field, 
and this process is governed by Faraday’s Law of induction.  
V = -N(dɸ/dt)                                                       [2] 
This change in magnetic flux over time induces a time-varying voltage in a coil, but 
generating a varying magnetic field requires transverse magnetization.  
 The magnetic moment of the bulk magnetization (M0) is precessing around B0 at a 
specific frequency known as Larmor frequency. Larmor frequency is dependent on static 
field strength and governed by the following equation… 
B0 (γ)  = ω                                                              [3] 
Where B0 is the magnetic field strength (Tesla), γ is the gyromagnetic ratio (nuclei 
dependent) and ω is the Larmor frequency.  
 
By taking the bulk magnetization along the Z-axis and tipping it into the transverse plane, 
voltage can be generated by the varying magnetic field as M0 precesses around B0. The 
perturbation of the bulk magnetization at equilibrium is known as excitation and can be 
accomplished with an external radio frequency (RF) magnetic field known as B1. 
Resonance is achieved when the frequency of the B1 RF pulse matches Larmor frequency 
– also matching the frequency of the static B0 field. The flip angle determines the amount 
of magnetization flipped into the transvers (XY) plane and is governed by…  
                                                                                                                             [4] 
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Figure 1.3 The B1 Magnetic Field Flips the Net Magnetization into the Transverse 
Plane. A 90º RF pulse along the X axis flips M0 into the XY-plane allowing for current 
generation.  
 
 
The time during which the B1 field is turned on determines the flip angle, and when turned 
off, the nuclear spins return to align along the static magnetic field. The process is known 
as relaxation and occurs as a longitudinal and transverse component.  
 The time constant which describes how the magnetization returns to equilibrium 
along the Z-axis (longitudinal) is known as T1 or spin-lattice relaxation time. The 
longitudinal relaxation rate, R1, has an inverse relationship with T1. T1 is governed by the 
following equation…  
                                                 Mz = M0 (1 – e-t/T1)                                                           [5] 
 
Figure 1.4 Schematic of an Exemplary T1 Recovery Curve. Longitudinal 
magnetization tends to grow with time constant T1. 
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The time constant which describes how the magnetization returns to equilibrium in the 
XY-plane (transverse) is known as T2 or spin-spin relaxation time. The transverse 
relaxation rate, R2, has an inverse relationship with T2. T2 is governed by the following 
equation… 
                                                  Mxy = M0 (e
-t/T2)                                                           [6] 
 
Figure 1.5 Schematic of an Exemplary T2 Decay Curve.  Transverse magnetization 
tends to decay with time constant T2. 
 
 
In conjunction with the B1 field, magnetic field gradients are used (Gx, Gy, Gz) for more 
specific excitation and are the key behind pulse sequence programming.  
1.4.2 Siloxane Selectivity  
 As the transverse magnetic field precesses around the Z-axis, a current is induced 
in a coil of wire located around the X-axis. A sine wave is produced by plotting this current 
as a function of time, and this signal is known as Free Induction Decay (FID). The magnetic 
field gradients are employed in a way allowing for the acquisition of the FID. With the help 
of the Fourier Transform, this signal can be converted into the frequency domain and aid 
in siloxane selectivity via the chemical shift phenomenon. 
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Figure 1.6 Free Induction Decay Schematic. FID (time domain) converted to the 
frequency domain using the Fourier Transform. 
 
The FID carries information from multiple frequencies centered around the Larmor 
frequency due to chemical shift. Chemical shift is brought about because of inherent 
differences in the resonance frequency of precessing protons [32]. The phenomenon is 
caused by variations in electron density due to differences in types of nuclei and molecular 
bonding [32]. In other words, the FID contains information from excited 1H protons, 
however, the precise resonant frequency will depend on the molecular structure and 
bonding of the 1H atom to other atoms. 
 The chemical shift of a specific nucleus is measured as the difference between its 
resonance frequency and a standard. This property is measured in ppm and given the 
symbol δ. 
                                                     δ = [(ν – νref) * 106]/ νref                                                                      [6] 
 
Therefore, while water, fat, siloxane and other organic compounds will all contain 1H, the 
chemical shift will be different for each. This information is used to create an NMR spectra 
where water falls at 4.7 ppm, fat falls at 1.0 ppm, and siloxane falls between -0.5 and 0.5.  
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Figure 1.7 Example NMR Spectra from Acquisition of Sample Containing Water, 
Fat and Siloxane. Each hydrogen-containing molecule resonates at a specific frequency 
(water at 4.7 ppm, fat at 1.0 ppm, and siloxane at 0.5 to -0.5 ppm) with respect to a 
standard. 
 
 
The nanoprobes used for cell labeling are able to generate signal without the background 
1H signal due to chemical shift. Proton imaging of siloxanes to map tissue oxygenation 
levels (PISTOL) employs a chemical-shift selective (CHESS) spin echo sequence to locate 
hexamethyldisiloxane (HMDSO) [33].  This sequence provides optional water and fat 
suppression along with a long echo time (>50 ms) for additional fat suppression [33]. T1 
mapping can quantify pO2 and provide functional oximetry essential to the nanoprobes as 
discussed further in Chapter 3. 
1.4.3 Fluorescence  
 The second modality utilized by the siloxane-based nanoprobes is fluorescence 
imaging for detection and ex vivo verification. While the modality requires penetration of 
light at depths unsuited for most in vivo studies, the cost effective nature, easy handling 
and lack of radioactivity in fluorescent tools has renewed interest via implementation with 
other modalities [34]. Optical fluorescence has been shown to aid in imaging of specific 
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tumor-associated molecular targets and is a promising tool for integration with multiple 
imaging systems [35].  
 A fluorophore is a fluorescent chemical compound capable of absorbing energy and 
re-emitting light of a specific wavelength upon light excitation [36]. Each fluorophore has 
an excitation and emission spectra.  
 
Figure 1.8 Example Excitation/Emission Spectra of Undefined Fluorophore. The 
excitation bandwidth  (peak near 450 nm) and emission bandwidth (peak near 575 nm) 
allow for light detection of a specific fluorophore. 
 
 
 
 
 
 
 
 
16 
 
CHAPTER 2 
NANOPARTICLE FABRICATION AND CELL TESTING 
2.1 Nanoparticle characterization 
 An effective way to synthesize siloxane-based nanoparticles has been discussed in 
depth [7,11]. Nanoemulsions can be used as delivery vehicles for imaging agents in order 
to monitor dynamic in vivo processes [37]. The emulsifying agent contains two distinct 
regions, and can be characterized as amphiphillic (having both hydrophilic and lipophilic 
parts). This characteristic of the emulsifier provides an excellent opportunity for particle 
loading and fabrication. The hydrophilic head will tend to shield the lipophilic tail from 
water and thus internalize a selected delivery agent [38]. For the following experiments, 
polydimethylsiloxane (PDMS) and a fluorescent component were chosen as the “center” 
of the nanoparticles for contrast and functional imaging upon integration with cells. 
Sonication -- another vital step in the fabrication process – involves using high energy 
sound waves to increase even dispersion of nano-sized particles [39]. Filtration following 
sonication increases uniformity amongst particle sizes and gives partial control of particle 
diameter.  
The following schematic illustrates the nanoprobe fabrication process and a specific 
methodology is presented shortly thereafter.  
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Figure 2.1 Nanoprobe Fabrication Process of PDMS/Nile Red-loaded Emulsions. 
Emulsifier with hydrophobic head and hydrophilic tail encapsulates PDMS/Nile Red to 
limit interaction between water and tail (repelled by water).   
 
 
 Nanoprobe synthesis occured at 70°C and particle composition was as follows, 55% 
deionized water, 40% siloxane, and 5% surfactant (emulsifying agent). Deionized water 
was attained from Arizona State University laboratory facilities. Previous fabrication 
experiments utilized HMDSO. For all labeling experiments, PDMS (Alfa Aesar, Ward Hill, 
Massachusetts, USA) with a molecular weight of 410 g/mol was utilized in place of 
HMDSO. The factors influencing this decision are discussed (Page 20). Solutol® HS 15, 
received as a gift from the BASF Corporation (Florham Park, New Jersey,USA), was used 
as the emulsifying agent. Two different fluorophores (Nile Red and Rhodamine B) were 
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used in emulsion synthesis, and their roles are discussed shortly. Emulsion batches were 
made in various batch volumes (most commonly 2 mL, 5mL, and 10 mL). Batches 
containing Nile Red were made in 5 mL volumes, while batches containing Rhodamine B 
were made in 2 mL volumes for conservation of resources.  
 Initially, HS 15 was heated and transitioned from a solid to liquid state within a 
20mL scintillation vial (Sigma-Aldrich; St. Louis, Missouri, USA). Deionized water was 
measured out accordingly and placed in a vial. This vial was placed on a heat/stir plate 
within a water bath. After the system reached 70°C, as measured by a temperature probe, 
HS 15 (in liquid state) was added to deionized water and allowed to mix for 2 minutes.  
 
 While mixing occurred, PDMS and a fluorophore were combined via two different 
methodologies. For Nile Red (Fisher Scientific; Waltham, Massachusetts, USA), 
ethanol was used to dissolve Nile Red at a ratio of 3.9 mg/mL. Once dissolved, Nile 
Red/ethanol was added to PDMS at a volume resulting in 0.1mM final Nile Red 
dye concentration in the emulsion. The dye was added on a heat/stir plate for 5 
minutes at 70°C in an effort to force ethanol evaporation. 
 For Rhodamine B, PE (Lissamine Rhodamine B) dissolved in chloroform was 
purchased from Avanti Polar Lipids, Inc (Alabaster, Alabama, USA). A proper 
volume to result in 0.1mM of Rhodamine in the final emulsion was measured and 
placed in a vial. Using a Rotovap (Buchi Corporation; Flawil, Switzerland), this 
compound was gently heated at 40°C for an hour. Following evaporation, 
Rhodamine was placed under a vacuum overnight to ensure the absence of 
chloroform. PDMS was then added to the chloroform-free Rhodamine.  
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The PDMS/fluorophore combination was added to the deionized water/surfactant mixture 
in a drop-by-drop fashion to allow for particle formation. The mixture was allowed to sit 
at 70°C for 15 minutes prior to sonication. Sonication occurred for a total of 45 minutes (3, 
15 minute intervals) at 150W and a duty cycle of 50%, using an Omniruptor 4000 
Ultrasonic Homogenizer (Omni International; Tulsa, Oklahoma, USA). The sample was 
de-bubbled and filtered with CELLTREAT (Celltreat Scientific; Shirly, Massachusetts, 
USA) 0.22µm syringe filters 10 times prior to particle size measurement. Nanoparticles 
were characterized using Delsa Nano Particle Size Analyzer (Beckman Coulter; Pasadena, 
CA, USA) through Dynamic Light Scattering (DLS).  
 Particle size typically ranged from 50nm – 150nm following sonication and 
filtration. Peak number average of particle diameter was taken from 8 samples with an 
average diameter found to be 98.24 ± 28.3 nm.  
 
Figure 2.2 Number Average Measurement of Sample Size by Dynamic Light 
Scattering. Nanoparticle sample as measured by DLS with peak diameter number 
average of 84.9 ± 21.2. 
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 These particles are used in a method of labeling known as direct labeling. This 
methodology is well-established and cost effective, with the pitfalls being signal decay 
over time with mitotic division [40]. There are three mechanisms by which the 
nanoparticles likely enter the cell: direct diffusion across the cell membrane, endocytosis, 
and transport across ion channels [41]. While labeling via the ion channels is highly 
unlikely, particle size and charge is an important aspect to consider when assuming the 
processes by which the cell is labeled. Loosely speaking, the smaller the particle size the 
better the odds to permeate the cell membrane. Thus, it is encouraging to see the particles 
formed at the nano-scale. A necessary study moving forward is characterizing the zeta 
potential of the particles. Understanding the electrokinetic potential of the nanoprobes 
would go a long way in better defining the mechanisms by which the cell becomes labeled. 
 The decision to use the heavier siloxane, PDMS, as opposed to the more 
traditionally used HMDSO in literature had to do with stability. HMDSO nanoparticles 
were found to undergo phase separation shortly after synthesis, whereas particles fabricated 
with PDMS did not separate remaining stable over longer periods of time. Additionally, 
nanoprobes were synthesized with both Nile Red and Rhodamine B. Nile Red was used as 
per the protocols of previous literature [11], but was found to cause toxicity in longer 
migration studies using neural stem cells (Chatper 2.2). For this reason, Rhodamine B was 
integrated into the particles and showed a decrease in long-term toxicity of neural stem 
cells. However, Rhodamine B proved more susceptible to photobleaching than Nile Red, 
and care was taken to preserve signal during experimentation.    
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2.2 Effects of labeling on NPSCs 
[A special acknowledgement to Caroline Addington for NPSC harvest and maintenance, 
and figure]  
 
2.2.1 NPSC harvest and maintenance  
 Neural progenitor stem cells were harvested from the medial and lateral germinal 
eminence of pups within the pregnant C57BL/6 mouse on the 14 and ½ day of pregnancy. 
Cells were placed in growth factor-embedded media and cultured in suspension. For 
optimal conditions, cells were used experimentally between passage No.’s 3 and 6.  
 Working NPSC media was created in 100mL batches. 94.3 mL of Dulbecco's 
Modified Eagle Medium (DMEM, Life Technologies; Carlsbad, CA, USA) was added to 
2.0mL of glucose (6 ng/mL, Arcos Organics; Geel, Belgium)in deionized H2O, 0.5 mL of 
HEPES buffer (5mM, Sigma-Aldrich), 0.1 mL of progesterone (62.9 ng/mL, Sigma-
Aldrich), 1.0 mL of putrescine (9.6 µg/mL, Sigma-Aldrich), and 7.32 uL of Heparin (25 
mg/mL, Sigma-Alrich). At this point, media filtration took place using a 0.22um PES 
Corning disposable vacuum filtration system (Fischer Scientific) to remove potential 
contaminants.  Following filtration, 2.0 mL of B27 growth supplement (1X, Life 
Technologies), 0.2 mL of insulin (5 µg/mL, Sigma-Aldrich), 50µL of transferrin (5 µg/mL, 
Sigma-Aldrich), and 9.65 µL of sodium selenite (5 ng/m, Sigma-Aldrich). 20µL of 
Epidermal growth factor (EGF) (20 ng/mL, Sigma-Aldrich.) and 25µL of fibroblast growth 
factor (FGF) (5 ng/mL, Sigma-Aldrich) were added to the media to limit stem cell 
differentiation. 
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 Neural stem cells were labeled with 10 µL of nanoparticles per 1.0 mL of working 
media for an incubation time of 1 hour. Following incubation, cells were lightly spun down 
and re-suspended (still in neurosphere form) using nanoparticle-free NPSC media. NPSCs 
were labeled in “neurosphere” form as shown below. At this point, labeled cells were used 
in various experiments.  
 
Figure 2.3 Neurospheres Labeled with 10 µL/mL of Nanoprobe for One Hour. (A) 
Brightfield image of NPSCs, (B) Fluorescent image of NPSCs (excitation: 570, emission: 
590), (C) Overlay 
 
 
2.2.2 Viability 
 
NPSCs were labeled using previously discussed methods. Following the nanoprobe 
labeling protocol, cells were spun down and dissociated back into single cell form for 
quantitative purposes. Calcein AM live stain (Biotium; Hayward, CA, USA) was used to 
measure viability. Cells with co-localized signal from Nile Red and calcein AM were 
considered viable and labeled while cells exhibiting signal from only Nile Red were not. 
Viable and labeled cells were normalized against unlabeled cells for quantification.  
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Figure 2.4 Labeled NPSC viability. Effective labeling was characterized by Nile Red (A) 
and shown viable by calcein AM (B). Co-localized signal (C) was used to determined % 
viability normalized to labeled cells (D).  
 
 
 Successful labeling of NPSCs was displayed at 75% viability with respect to 
unlabeled cells. While cells were shown to be both labeled and viable, increased viability 
is desirable as reported with similar stem cell labeling [18, 42]. Further studies were done 
to assess labeling effects on stem cell proliferation and migration.  
 In comparison to other labeling viability results, cell survival seems relatively low 
for these labeled cells. One potential study which could shed light on ways to increase 
viability is trypan blue exclusion or an MTT assay as shown by other studies [21, 43]. 
However, the MTT assay becomes difficult with the cells maintained in suspension. This 
study would require additional factors forcing the cells to adhere to plate surfaces for long 
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periods of time and eventually result in differentiation. The trypan blue exclusion stains 
dead cells by passing through the cell membrane. Utilizing this method may provide 
different results which appear more comparable with similar literature [21].   
 It’s also important to consider the balance between labeling payload and incubation 
time with respect to viability. There exists an interesting balance between cell survival and 
amount of nanoemulsion contained within the cell. Ideally, the more emulsion the better 
for increased visualization during imaging. However, this increase can also be associated 
with negative effects on cell dynamics.  
 
2.2.3 Migration  
Following labeling, NPSC neurospheres were plated on poly-l-lysine and laminin 
coated surfaces. Neural progenitors have been shown to migrate on laminin surfaces and 
adhere, absent of migration on poly-l-lysine surfaces [44].  Neurospheres were plated in 
coated 24-well plates at a density of 25 neurospheres per cm2 in growth factor-free media. 
4 different well groupings were established each with n = 6: labeled cells on laminin, 
unlabeled cells on laminin, labeled cells on poly-l-lysine, unlabeled cells on poly-l-lysine. 
These groupings allowed for comparison between labeled and unlabeled cell processes. 
Diametrical measurements of neurosphere migration allowed for a quantitative comparison 
between labeled and unlabeled cells.  
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Figure 2.5 NPSC Radial Migration Out to Day 6 on Poly-l-lysine and Laminin. Both 
unlabeled (A-C) and labeled (D-F) NPSCs showed minimal migration on poly-l-lysine. 
However, significant radial migration was seen for both unlabeled (G-I) and labeled cells 
on laminin (J-L). Scale bar represents 150 microns.  
 
 
Figure 2.6 Quantification of NPSC Radial Migration. Diametrical measurements 
allowed for assessment on days 3 and 6 normalized to baseline measurements taken on 
26 
 
day 0 (A). Radial migration increased on laminin for labeled and unlabeled cells and 
remained constant on poly-l-lysine at days 3 (B) and 6 (C). No significant differences 
were observed between radial migration of unlabeled and labeled NPSCs on laminin at 3 
(B) and 6 (C) days. **p<0.01 compared to poly-L-lysine controls. 
 
 Comparison of unlabeled and labeled NPSCs is promising as the labeled cells 
behave as expected. Labeled cells migrate on laminin with no significant difference 
compared to unlabeled cells. Similarly, cells on poly-l-lysine withhold from migration for 
both labeled and unlabeled. It is encouraging to see the labeling process does not have 
significant effects on neural progenitor’s ability to migrate.  
 NPSC migration is a vital step with respect to integration following transplantation. 
The fate of these cells appear to be more indicative of their surrounding environment  rather 
than intrinsic properties, thus progenitor cell migration/differentiation into specific cell 
types for a targeted region is the foundation for potential therapies [45]. With this in mind, 
visualization of labeled NPSCs migration gives hope to tracking these dynamics in vivo 
and comprehending the underlying causes of integration.  
2.2.4 Proliferation  
 The Quant-iT PicoGreen dsDNA assay kit (Life Technologies; Carlsbad, CA) was 
used to assess proliferation of NPSCs on poly-l-lysine at 6 days. Labeled and unlabeled 
neurospheres were plated on poly-l-lysine in 24-well plates (n=6) at a density of 25 
neuospheres/cm2. After 6 days, wells were scratched and lysed for 72 hours in humid 
conditions with Proteinase K buffer. Cells were transferred to a 96-well plate for 
compatibility with a fluorescence-based microplate reader. Double strand DNA 
quantification was performed using the assay kit. The quantitation reagent was added to 
the samples and a cell count was performed following plate reading. 
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Figure 2.7 Cell count Determined after NSPC Proliferation on Poly-l-lysine for 6 
Days. Labeled and unlabeled cells are not significantly different and cell counts were 
normalized to values on day 0.  
 
It is promising to see labeled cells proliferating at rates similar to unlabeled cells. One 
important factor to consider regarding proliferation is the decreasing concentration of 
emulsion with proliferating cell lines. There is a finite amount of emulsion loaded within 
the initial labeled cells. Signal detection will become more difficult with continuing cell 
division, and must be acknowledged when considering long-term studies.   
 
2.3 Cancer cell and tumor spheroid labeling  
 Human prostate carcinoma epithelial cell line, 22Rv1 (ATCC; Manassas, Virginia), 
was used for cancer cell labeling studies. Mouse embryonic fibroblast cell line, NIH/3T3 
(ATCC) was used in conjunction with 22Rv1 cells for tumor spheroid formation.  
 Initial cancer cell studies were performed via direct labeling. As previously stated, 
cancer metastasis and tumor spheroid research could prove valuable areas for applicable 
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cell labeling. Labeling protocol for the cancer cells has remained consistent with the NPSC 
cells, however, recent research has shown the cells increased ability to handle longer 
incubation time.  
 22Rv1 cells were plated on T75 cell culture flasks (Fisher Scientific; Hampton, 
New Hampshire) and cultured using Rosewell Park Memorial Insititue (RPMI) media 
(ATCC). For labelling, nanoparticles were incubated with 22Rv1 cells once the cells 
reached 80-95% confluency at a 10 µL/mL concentration for 1-3 hours. After the 
incubation period, the media/nanoparticle mix was removed and the cells were washed 
with 3 mL of Dulbecco`s Phosphate Buffered Saline (Thermo Scientific; Waltham, 
Massachusetts) for 2-3 minutes. DPBS was removed and cells were trypsinized using 5 mL 
of Trypsin 0.25% (1X) solution (Thermo Scientific). At this point, the cells lost adherence 
to the flask surface, were removed, spun down, re-suspended and ready for experimental 
use. Labeled cells were used to make imaging phantom (discussed more in depth in Chapter 
3).  
 Multicellular tumor spheroid formation methods are well established [31, 46]. In a 
100mL Pyrex media bottle, a 1% agarose (Sigma-Aldrich; St. Louis, Missouri) gel solution 
was prepared using non-supplemented Dublecco’s Modified Eagle’s Medium (DMEM). 
This mixture was autoclaved, and 50µL of solution was placed in each well of a 96-well 
plate before solidifying. While pipetting, care was taken to ensure no bubble formation in 
the agarose gel. The 96-well plate was covered from light and allowed to cool for 1.5 hours.  
 NIH/3T3 and 22Rv1 cells were cultured alongside agarose plating. Cells were only 
utilized once (at minimum) 80% confluent at the time of the study. Cells were washed with 
DPBS, trypsinized, and re-suspended for use.  The two cell lines were mixed in a 1:1 ratio 
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in an equal amount of DMEM and RPMI to a cell concentration of 600,000 cells/mL (final 
seeding density 120,000 cells/well). 200 µL aliquots were pipetted into each agarose-
coated well and incubated. RPMI/DMEM mixture was added every 24-48 hours depending 
on nutrient uptake. Spheroids were ready for experimental use after 72 hours.  
 
Two different methods were used to label the tumor spheroids with nanoparticle.  
 
 Following spheroid formation, nanoemulsion was added to the DMEM/RPMI 
mixture at a concentration of 10 µL/mL and placed in the spheroid-containing 
wells. After an hour of incubation, the nanoemulsion/media solution was removed 
from the well. Spheroids were washed three times with PBS and placed in new 
wells containing nanoemulsion free media.  
 NIH3T3 and 22Rv1 cells were labeled in T75 cell culture flasks as previously 
mentioned. After labeling, cells were trypsinzed, washed, and re-suspended to be 
seeded in hopes of tumor spheroid formation. 200 µL aliquots of the labeled 
NIH3T3 and 22Rv1 cells were added to the agarose coated wells in fresh, 
nanoemulsion free media.  
 
Both labeling methodologies were examined by fluorescence microscopy.  
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Figure 2.8 Tumor Spheroids Labeled with Nanoemulsion after Structural Formation. 
(A) Bright Field image  (B) Fluorescence image (C) Overlay. Scale bar is 200 microns. 
 
 
Figure 2.9 Labeled NIH/3T3 and 22Rv1 Cells Attempting to Form Tumor Spheroid 
at 72 Hours Post-labeling. (A) Bright Field image (B) Fluorescence image (C) Overlay 
Scale bar is 200 microns. 
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 Figure 2.9 and 2.10 would lead to the conclusion of labeling after spheroid 
formation as the better method. However, these images do not tell the full story. Labeling 
after spheroid formation likely does not provide uniform labeling throughout the structure. 
For purposes of determining hypoxic regions within an in vivo tumor model, the nanoprobe 
would need to evenly label the spheroid to give accurate oximetry information. In this case, 
cells on the external portion of the spheroid are likely receiving more nanoemulsion than 
those on the interior.  
 Unfortunately, while the cells labeled pre-spheroid formation aggregated in the 
center of the well, complete spheroid structure was not achieved. This methodology is 
preferential. Labeling only the 22Rv1 cancer cells and leaving the NIH/3T3 fibroblasts 
unlabeled is one potential future study capable of achieving more uniform labeling. Tumor 
spheroid research is being revisited, and the added ability of oximetry could fuel more 
efficient evaluation of potential cancer agents.  
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CHAPTER 3 
SILOXANE SELECTIVE MAGNETIC RESONANCE IMAGING 
3.1 Calibration at 7T 
 All imaging work took place on the Pre-clinical Bruker (Billerica, MA, USA) 7T 
magnet at Barrow Neurological Institute/Arizona State University facilities within St. 
Joseph’s Hospital (Phoenix, AZ). As previous experiments utilizing proton imaging of 
siloxane to map tissue oxygenation level (PISTOL) were done on a 4.7T magnet, 
calibration was required with the change in field strength.  
 Calibration experiments were done to characterize the effects of pO2 on spin lattice 
(longitudinal) relaxation rate, R1. The interaction between oxygen and HMDSO, an oxygen 
reporter molecule, is advantageous in quantitative MR oximetry. The oxygen molecule is 
paramagnetic and tends to cause nuclear spins to relax at faster rates – therefore increasing 
the R1 and R2 of the siloxane. A requirement for siloxanes used in quantitative MR oximetry 
is high oxygen solubility. In this way, increased presence of oxygen will cause an increase 
in relaxation rate.  
 Based on previously established ways to model tissue oxygenation [47, 48], we can 
consider oxygen reporter molecules with high concentrations of oxygen in their vicinity 
and conversely, oxygen reporter molecules with low concentrations of oxygen in their 
vicinity. The high solubility of oxygen in the reporter molecule allows us to look at the 
relaxation rate for each reporter molecule (high O2 conc. and low O2 conc.) as a molar 
weighted average. The net relaxation rate can be evaluated considering x as the molar 
fraction of oxygen by the following equation  
       R1 = (1 – x)R1d + x(R1d + R1p) = R1d + x(R1p)                                   [7] 
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Where R1d is the relaxation rate when no oxygen is present (anoxic conditions), R1p is the 
paramagnetic component of the relation rate due to oxygen uptake, and R1 is the relaxation 
rate (1/T1). The partial pressure of a gas is directly related to the mole fraction based on the 
following relationship.  
                                                        P1 = x(Ptot)                                                                 [8] 
Where P1 is the partial pressure of a gas, x is the mole fraction, and Ptot is the total pressure 
of the gas. Similarly, the partial pressure of oxygen (pO2) is related to the mole fraction by 
an agent dependent constant (k) that determines the solubility of oxygen in the agent. 
                        pO2 = k(x)                                                                 [9] 
Therefore, the relationship between longitudinal relaxation rate and pO2 becomes  
                                                      R1 = A’ + B’*(pO2)                                                   [10] 
where A’ = R1d and B’ = R1p/k 
 Longitudinal relaxation rate is a function of temperature, and thus the constants A’ 
and B’ have an assumed linear dependence on temperature. This relationship can be 
defined as  
           A’ = A + C*(T)                                                        [11] 
           B’ = B + D*(T)                                                         [12] 
The goal of defining these constants for HMDSO and PDMS at higher field strength was 
in mind when running initial experiments.  
 Neat HMDSO (Sigma-Aldrich) was placed in four John Young NMR tubes at 200 
µL volumes. Using a sealed environment free from ambient air, samples were bubbled with 
gas at different concentrations of oxygen with a Hypoxydial™ Gas Blender (Starr Life 
Sciences; Oakmont, Pennsylvania, USA). These concentrations included 0% (anoxic), 5%, 
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10% and 21% oxygen. Samples were sealed so that proper oxygen concentrations remained 
unchanged upon interaction with the environment.  
 The four J. Young NMR (Wilmad-Labglass; Vineland, NJ, USA) tubes were placed 
together and put into the bore of the magnet on top of a heated water bath extension 
provided by Bruker. Temperature was measured with an MR compatible temperature probe 
to confirm water bath measurements. Using the PISTOL sequence developed by Dr. 
Vikram Kodibagkar and implemented on the Bruker system by Rohini Shankar, frequency-
selective signal detection of the HMDSO was achieved. T1 mapping was employed to 
measure the longitudinal relaxation rate (R1 = 1/T1). The experiment was repeated at for a 
total of four different temperature points: room temperature (23.5ºC), 27ºC, 32ºC, and in 
vivo temperature (37ºC). 
 
Figure 3.1 Neat HMDSO Signal Acquisition via Proton Imaging of Siloxanes to map 
Tissue Oxygenation Level.  Repetition time (TR = 55s) at 37ºC displays signal from all 
four John Young NMR tubes. 
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Figure 3.2 T1 Mapping of Neat HMDSO-containing John Young NMR Tubes in 21%, 
10%, 5%, and 0% Oxygen Concentrations. A decreased T1 relaxation time is displayed 
with increasing pO2.  
                                              
R1 values at varying temperatures were plotted as a function of pO2 (in torr). In this way, 
determination of the constant, A’, occurs at the intercept of the linear fit because when pO2 
is equal to zero torr, R1 = A’. Similarly, the constant B’ can be determined by the slope of 
the linear fit. When pO2 is not equal to zero, the longitudinal relaxation rate is governed by 
the paramagnetic component of relaxation rate due to oxygen uptake based on amount of 
solubilized oxygen. The constants C and D can be determined by plotting A’ and B’ values 
with respect to temperature. Based on the following equation, a more accurate and reliable 
calculation of pO2 can be achieved. 
   R1 = A’ + B’*(pO2) + C*T + D*T*(pO2)                                [13] 
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Figure 3.3 Neat HMDSO R1 Values of 0%, 5%, 10%, and 21% Oxygen 
Concentrations at 37ºC. Calibration constant A’ = 0.11631 ± 0.002 based on linear fit, 
calibration constant B’ = 0.000988 ± 0.00003, R2 =0.99751 
 
 
Figure 3.4 Neat HMDSO R1 Values at Varying Temperatures. Values decrease slightly 
with increasing temperature at temperatures 23.5ºC, 27ºC, 32ºC, and 37ºC. 
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After determining the A’ and B’ values at each temperature point, these values can be 
plotted as function of temperature. C and D constants can be determined via the 
relationships in equation 11 and 12.  
 
Figure 3.5 Neat HMDSO Temperature Dependence of Constant A’ at 7T. Linear 
fitting resulted in calibration constants A = 0.1714 ± 0.00587 and C = -0.00148 ± 0.002, 
R2 =0.944  
 
 
Figure 3.6 Neat HMDSO Temperature Dependence of Constant B’ at 7T. Linear fitting 
resulted in calibration constants B = 0.0012 ± 0.000004 and D = -5x10-6 ± 0.000001, 
R2=0.8865 
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Determination of these constants allows for a complete picture of relaxation rate with 
respect to pO2. Similar experiments were done using PDMS at 37ºC, however, a leak in 
one of the John Young NMR tubes caused PDMS at 0% oxygen to interact with ambient 
air and behave more like PDMS at an oxygen concetration close to atmospheric levels. 
Therefor, this value is ignored.  
 
Figure 3.7 T1 Mapping of Neat PDMS-containing John Young NMR Tubes at 21%, 
10%, 5%, and 0% Oxygen Concentrations. A leak in the “0% concentration” tube 
effected data and was ignored when plotting R1 with respect to pO2. 
 
 
Figure 3.8 Neat PDMS R1 Values at 5%, 10%, and 21% Oxygen Concentrations 
(37ºC). Calibration constant A’ = 0.21156 ± 0.00608 based on linear fit, calibration 
constant B’ = 0.00109 ± 0.00007, R2 =0.9926 
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For PDMS-based nanoemulsions, similar experiments were run at 23ºC for calculations 
involving in vitro samples and 33.5ºC (discussed later) for in vivo calculations. 
 
 
Figure 3.9 T1 Mapping of PDMS Nanoemulsions in John Young NMR tubes at 21%, 
10%, 5%, and 0% Oxygen Concentrations. A leak in the 5% oxygen concentration tube 
skewed data and was ignored for constant determination.  
 
After the R1 relaxation rates were plotted against pO2, it was determined the 5% oxygen 
sample was incorrectly processed. The average T1 value within the 5% and 10% samples 
were 3.43 and 3.28 seconds respectively at 33.5ºC. While these numbers continue the 
expected trend of decreased R1 value with decreased pO2, linear fitting showed the 5% 
sample to deviate from the expected trend based on PDMS and HMDSO data. For this 
reason, the 5% sample was excluded from linear fitting to attain constants.  
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Figure 3.10  PDMS Nanoemulsion R1 values at  0%, 10%, and 21% Oxygen 
Concentrations (23ºC). Calibration constant A’ = 0.234 ± 0.00967 based on linear fit, 
calibration constant B’ = 0.00127 ± 0.00012, R2 =0.97988 
 
Figure 3.11  PDMS Nanoemulsion R1 Values at 0%, 10%, and 21% Oxygen 
Concentrations (33.5ºC). Calibration constant A’ = 0.20948 ± 0.00176 based on linear 
fit, calibration constant B’ = 0.00122 ± 0.000024, R2 =0.992 
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While calibration work will not inherently change the relxation rates or MR-based 
parameters, proper constants are important for accurate oximetry. PDMS nanoemulsions 
were calibrated at room temperature (23ºC) and a temperature near in vivo (33.5ºC). 
Unfortunately, 33.5ºC was the highest temperature measured when maxing out the water 
bath provided by Bruker. The water bath has the capability to heat to 37°C, but was 
malfunctioning during the experiment, and could not heat to the appropriate level. While 
it is not precisely in vivo temperature, it is a close approximation. Additionally, the values 
attained while measuring values of PDMS at 37°C appear to be comparable to emulsion 
values at 33.5°C. One way to confirm these values is to acquire the C and D constants as 
shown in figures 3.5 and 3.6. These constants allow for a more complete look at relaxation 
rate.   
 It is encouraging to see T1 relaxation time decrease with increasing oxygen 
concentration. It has been shown that T1 increases with increased temperature and thus, a 
decrease in R1 is displayed. These relationships can be seen in calibration of HMDSO, 
PDMS, and PDMS-based nanoemulsions.  
 In comparison to previous values acquired at the University of Texas-Southwestern 
by Dr. Kodibagkar and his students (specifically Ujjawal Rastogi), the constants acquired 
using the 7T magnet are comparable. In theory, T1 relaxation times should increase with 
higher field strength. This is due to the increased net bulk magnetization. Higher energy 
spin states outnumber lower energy spins to a greater extent at higher fields. These changes 
in T1 relaxation times require calibration at new fields and with new siloxanes.  
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3.2 MR imaging of NPSCs 
 As previously discussed in Chapter 2, NPSCs have been labeled and imaged using 
fluorescence microscopy. NPSCs are imaged in 2.0 mL microcentrifuge tubes (Eppendorf; 
Hamburg, Germany) surrounded by a 2% agarose gel (Sigma-Aldrich). Agarose gels were 
fabricated by placing 200mg of agar in 10 mL of deionized water within a 20 mL glass 
vial. This mixture was heated above 90ºC while stirred.  
 Cells were labeled as per previous studies’ protocol, spun down in Falcon™ 15mL 
Conical Tubes (Fisher Scientific), and re-suspended in 1.0 mL fresh, nanoemulsion-free 
media. A 750µL base layer of agar was placed in the 2.0 mL microcentrifuge tube and 
placed on ice for cooling. Once solidified, 1.0 mL of re-suspended, labeled NPSCs were 
pipetted on top of the base layer. This sample was centrifuged for a second time (1000 rpm) 
for 5 minutes, with a cell pellet forming on top of the initial agarose layer. A second 1.0 
mL layer of liquid agarose was pipetted gently on top of the cell pellet so as to minimize 
bubble formation. 
 It is important to surround the cell pellet with agarose and keep the pellet away 
from tube surfaces because of the susceptibility artifact. This artifact is caused by 
interaction between surfaces which tend to distort the applied magnetic field via local 
inhomogeneities [49].  Echo-planar imaging (EPI), a technique utilized by PISTOL, is 
especially prone to this artifact due to the inhomogeneities near interfaces [50]. 
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Figure 3.12 Dual-modality Imaging of Labeled NPSC Pellet. T2-weighted scout scan 
of labeled stem cell pellet submerged in agarose gel (A), Siloxane-selective image (B), 
Fluorescence image: excitation – 500 nm, emission – 560 nm (C)  
 
 Figure 3.12 shows the dual-modality nature of the labeled NPSCs. 400,000 NPCs 
were labeled and imaged using a siloxane-selective multi-slice, multi-echo image. 
Fluorescence imaging was done using an Invitrogen bioluminescence/fluorescence 
imaging device (Life Technologies). However, the MR image does not give the precise 
signal detection desired, and following work tried to combat sensitivity issues involving 
detection.  A promising cell pellet imaging phantom was produced using 400,000 cells and 
shifted signal (susceptibility artifact) was detected. To ensure the signal was in fact from 
the nanoprobe-labeled cells, chemical shift imaging was employed.  
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 Chemical shift imaging maps the spatial distribution of nuclei associated with a 
specific chemical shift (ie. Hydrogen groups associated with water, lipids, or siloxanes) 
[51]. In this way, we can look at the NMR spectra within a specific location and determine 
if siloxane signal is present.  
 A metabolite map was created using computing program, Matlab (Mathworks, 
Natick, Massachusetts, USA), and overlaid with an anatomical T2-weighted image to 
display location of siloxane. As displayed in Chapter 1.4, PDMS is located 4.2 – 5.2 ppm 
from water on an chemical shift spectra. When centering water’s resonance at 0 Hz, PDMS 
is located roughly 1425 Hz away from water.  
   
Figure 3.13 Chemical Shift Imaging and Metabolite Map of Labeled NPSC Pellet. CSI 
shows signal from nanoprobe-labeled NPSCs (signal near 1425 Hz away from water at 0 
Hz). (A) T2-weighted anatomical image with marker for NMR spectra viewing (B) 
Metabolite map overlay (C) Chemical shift imaging NMR spectra  
45 
 
These results showed the presence of siloxane signal in NPSCs. The yellow marker shows 
the voxel at which the CSI spectra was created. After imaging of siloxane labeled cells was 
shown feasible, in vivo experiments took place tranplanting labeled NPSCs into the mouse 
brain.  
 Animal experiments were done in accordance with approval by the Institutional 
Animal Care and Use Committee at Arizona State University. C57BL/6 mice were 
anastethized and placed on a stereotactic device. Incisions were made allowing for 
Hamilton needle (Hamilton; Reno, NV, USA) injections in correlation with a nanoinjector. 
5 µL of labeled NPSCs in working media were injected and the incision area was sutured 
shut. This method has yet to been validated with MR data, but experimental design is being 
altered to overcome sensitivity issues.  
However, in the controlled cortical TBI model, MR signal has been acquired from 
the PDMS-based nanoprobes. Using a 2 mm diamter electromagnetic piston (Leica 
Microsystems; Wetzlar, Germany), an injury was inflicted on C57BL/6 mice. The piston 
was delpoyed at 5m/s for 2 ms at a depth of 1.5 mm into the brain. Animals were injured 1 
week prior to injection of 10 µL of nanprobe and subsequent imaging.  
 
Figure 3.14 Siloxane Selective MR Data Overlaid on Grayscale T2 Anatomical Images. 
Displayed are siloxane signal (A), air breathing (B) and oxygen breathing (C) with mean 
pO2 values of 54 torr and 154 torr respectively.  
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Air and oxygen breathing help to verify the presence of siloxane, an oxygen reporter 
molucule, as the increased presence of oxygen should result in a decreased T1 relaxation 
time. The injection of PDMS-based nanoprobe helps to prove the concept of detection and 
oximetry for NPSC transplantation applications. The implementation in the traumatic brain 
injury model is ideal for long-term goals. The overall goal is theranostics, and neural stem 
cell transplantation has shown promising effects post-TBI. 
 Most recently, a similar imaging phantom was fabricated using slightly different 
labeling parameters. Due to sensitivity issues, an aim to increase labeling payload was 
targeted. Using 950,000 cells and a 3 hour incubation time, NPSCs were labeled. Instead 
of immersing the labeled pellet in two layers of agar, the NPSCs were washed in DPBS 
and re-suspended using 100 µL of agarose. This experiment best replicates the injection of 
a NPSC loaded gel, and brings the study closer to overcoming the sensitivity obstacles.  
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Figure 3.15 Dual-modality Imaging of Labeled NPSCs Suspended in Agarose. T2-
weighted scout scan of labeled NSPCs in 100 µL agarose gel (A), PISTOL image (B), 
Fluorescence image: excitation – 500 nm, emission – 560 nm (C)  
 
Increased incubation time and cell count provides an increased opportunity for detection 
and may hold the key to overcoming sensitivity issues. Future studies will acquire images 
using the PISTOL sequence at different repetition times in order to create a complete T1 
map. 
3.3 Cancer Cell MR imaging 
 Cancer cells were labeled using the same protocols discussed in Chapter 2. For the 
imaging phantom shown below (Figure 3.16), 4,000,000 22Rv1 cells were labeled, re-
suspended in agarose gel, and placed in 1 mm diameter Wilmad NMR capillary tubes 
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(Sigma-Aldrich). Similar samples were made in capillary tubes using 1,000,000 labeled 
cells and pure agarose absent of cells. This method was utilized in an attempt to quantify 
signal intensity with respect to cell count.  
 For tumor spheroid imaging, spheroids were labeled after structural formation as 
described in Chapter 2. Spheroids were immersed in agarose gel within 2.0 mL 
microcentrifuge tubes to minimize susceptibility.  
 
Figure 3.16 Siloxane Selective Imaging of Cancer Cells at Different Concentrations. 
PISTOL overlay on T2 anatomical image (A) with 4 X 106 cells in C, 1 X 106 cells D, 
and zero cells in E with mean. A mean pO2 value of 95 torr was determined for all cells. 
A multi-slice, multi-echo siloxane selective sequence is shown with signal corresponding 
to the cell containing tubes (B). 
 
The location of the signal in the PISTOL overlay is concerning. Cells were placed 
throughout the capillary tube and it is expected signal would be acquired across the entire 
diameter of the tube. Additionally, the mean pO2 values (at 95 torr) are less than we 
would expect in ambient air.  Again, longer incubation times could provide for a higher 
payload of nanoemulsion within the cells and potentially give a signal increase.  
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Figure 3.17 Dual Modality Imaging of Labeled Tumor Spheroid. T2-weighted scout 
scan of labeled tumor spheroid immersed in agarose gel (A), PISTOL image (B), 
Fluorescence image: excitation – 500 nm, emission – 560 nm (C)  
The number of averages in the PISTOL image was 64, and future experiments will vary 
the repetition time using this sequence to acquire a complete T1 map.  Figure 3.17 displays 
the ability to view labeled spheroids in vitro. With continued experimentation in the 
spheroid fabrication process, aims include a more uniformly labeled spheroid for a 
complete look at modeled hypoxic regions. It is encouraging to see localized signal from 
where the spheroid appears to be on the T2 anatomical image and correlating PISTOL 
imaging. Using a long echo time, signal from water and fat decrease while siloxane signal 
remains bright per its long T2.  
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CHAPTER 4 
DISCUSSION AND CONCLUSION 
 The sensitivity issues in imaging are a delicate balance, and further research needs 
to be conducted in order to determine the labeling “sweet spot”. On one hand, increasing 
the incubation time, and the amount of nanoparticle loaded into either NPSCs or cancer 
cells will increase MR signal. However, increased labeling could result in greater effects 
on cell functionality and thus, disrupting the processes essential for therapy/detection post-
transplantation. 
 From an imaging standpoint, higher field strength imaging will potentially result in 
more signal. A stronger magnet creates a larger discrepancy between high energy and low 
energy nuclear spins creating a larger bulk magnetization when a sample is exposed to an 
external magnetic field [52]. Additionally, signal to noise ratio increases at higher fields. 
Unfortunately, most clinical imaging is done at 1.5 and 3T fields at lower strength than the 
Bruker 7T. Nonetheless, signal detection is more than possible at the current fields, it 
becomes a matter of parameter optimization.  
 Considering a 5 µL injection into the mouse brain as per the established protocol 
calls for, and assuming all of that 5 µL is cell. Taking it another step further and assuming 
these cells were 100% labeled with nanoprobe. This assumption would leave, at best case 
scenario, 2 µL of siloxane for detection. While this value is entirely plausible for signal 
detection, actual conditions likely call for detection at near an order of magnitude less. 
 MRI has been shown capable of detecting single particles at the micron level [53]. 
Additionally MRI has proven able to detect single cells following transplantation [54].  
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 At small resolutions, particles of sizes 0.76 µm – 1.63 µm indicated T2 effects [53]. 
These experiments occurred on an 11.7T magnet, so for sake of comparison, taking the 
high-end particle size for a baseline detection estimation is necessary. With a particle 
diameter of 1.63 µm, the volume of one particle is 18.14 µm3. Based on the relationship 1 
mL is equivalent to 1 cm3, 1 µm3 is equivalent to 1x10-9 µL. Therefore, at 11.7T, MR effects 
are shown at contrast agent levels of 1.8x10-8 µL. And as noted by Shapiro et. al, detection 
of particles below 0.96 µm becomes difficult.  
 By looking at our earlier example – which considered 2 µL as the maximum amount 
of siloxane present within a 5 µL NPSC slurry injection -- it is fair to assume detection of 
nanoprobe within labeled cells is probable. However, there are some additional 
considerations to take into account.  
 Realistically, the maximum 2 µL estimation is generous and is more likely an order 
of magnitude less. The injection is not 100 percent cells, and these cells are not 100 percent 
labeled. A better estimation would be to consider the cells 10 percent labeled resulting in 
a maximum of 0.2 µL of siloxane injected into the brain. Again, the injected slurry is not 
an ideal injection and is more likely to give a maximum siloxane volume somewhere within 
the window of 0.1 µL – 0.2 µL. This cautious estimation still lies well within the limits of 
detection as displayed by Shapiro. With this in mind, identifying ways to increase siloxane 
detection is the next step in successful experimentation.  
 Iron oxide particles are considered superparamagnetic, and the term 
“superparamagnetism” refers to the behavior of the particle’s magnetic moment with 
respect to eliminating magnetic interaction in the presence of the external magnetic field 
[55]. Therefore, contrast is enhanced via “signal loss” or a darkening on T2 weighted 
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images. This occurs via the shortening of T2 relaxation rates and can be referred to as 
negative contrast. The siloxane contrast agents mentioned here work in a different way. 
These nanoprobes rely on the frequency-selective excitation of siloxane resonance and 
chemical-shift suppression of other 1H sources. This is considered a positive contrast agent 
due to the generation of signal on siloxane-selective sequences.  
 While at the core of both techniques lie interactions between magnetic moments 
and the external magnetic field, the siloxane contrast agents are susceptible to artifacts, and 
acquisition parameters must be optimized. Chemical shift edge artifacts [56, 57] can occur, 
but the more applicable concerns involve the susceptibility artifact and background signal 
elimination. These concerns can be addressed with increased attempts at boosting local 
field homogeneity (shimming) and suppression techniques. Fat resonance is of additional 
concern as the lipid bi-layer constructing most cell membranes tends to have a chemical 
shift near siloxane. Overcoming these issues is plausible, but they stress the emphasis on 
optimal conditions during acquisition.  
 Another consideration that will impact studies across the board is incubation time. 
Iron oxide studies have shown an overnight incubation with contrast agent (prior to 
washing) [54, 58], and an increase in iron oxide content within the cell with longer 
incubation times [58]. It’s rather intuitive to assume a longer incubation time will result in 
a higher loading yield. The original incubation time of one hour was determined based on 
the already low viability post-labeling, and the appearance of successful labeling on 
fluorescence microscopy after one hour. In comparison to other labeling techniques [21, 
42] the proposed incubation time tends to be on the low end. Of course, a longer incubation 
time is desired, but this also brings up viability and functionality questions. Previously, we 
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had seen migration viability concerns on the Day 6 time point, but re-testing viability, 
migration, and proliferation with a longer incubation time could be the key to in vivo signal 
detection.  
 In vitro studies have been promising, and increasing the amount of nanoprobe 
within the cell could be the factor that gives more promising in vivo data.  
 Additional in vivo data could be generated with cancer cells as injection limitations 
are less stringent. However, we must consider cell functionality amidst excessive loading.  
While tumor spheroids have been successfully labeled, forming spheroids out of pre-
labeled cells has shown issues in structural formation. Further studies will address some of 
the setbacks in this experimentation, and should provide a valuable oximetry tool for 
further cancer evaluation.  
 Contrast agents utilized in conjunction with 1H MRI have advantages in cell 
labeling applications. Contrast generation is a useful tool for in vivo tracking at the cellular 
level. Oximetry is beneficial for evaluating cancer metabolism and injury dynamics. A 
better understanding of the labeling process, and technique enhancement, will provide a 
valuable tool for therapy investigation and cell tracking.  
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